Metraipolis › archive › dc_162caea8d7f4
Drug sequestration and metabolite formation: key pharmacokinetic challenges for levosimendan use during ECMO support in cardiogenic shock — Europe PMC PMID:42032778
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42032778
- DOI
- 10.1186/s40560-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T07:03:51.499Z
- SHA-256 of the archived text
4631e7037c69ceeac767e7436c18734ad2cf985c9c67209b74417cec1b6356ed- Stable URL of this page
https://metraipolis.com/documento/dc_162caea8d7f4
How to cite
Drug sequestration and metabolite formation: key pharmacokinetic challenges for levosimendan use during ECMO support in cardiogenic shock — Europe PMC PMID:42032778 — Europe PMC (en), https://europepmc.org/article/MED/42032778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_162caea8d7f4 (Metraipolis archive dc_162caea8d7f4, sha256 4631e7037c69ceeac767e7436c18734ad2cf985c9c67209b74417cec1b6356ed)
BibTeX
@misc{dc162caea8d7f4,
title = {Drug sequestration and metabolite formation: key pharmacokinetic challenges for levosimendan use during ECMO support in cardiogenic shock — Europe PMC PMID:42032778},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42032778},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_162caea8d7f4; sha256 4631e7037c69ceeac767e7436c18734ad2cf985c9c67209b74417cec1b6356ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42032778. Agents can read the archived copy with the MCP tool read_document.